March 2026
1. SCARALLO L, Alvisi P, Bramuzzo M, Domanico A, et al
   Intestinal Ultrasound Scan in Acute Severe Ulcerative Colitis in children: a multicenter prospective study on behalf of the Porto IBD Working Group of ESPGHAN.
   Gastroenterology. 2026 Mar 16:S0016-5085(26)00232.
   

   >> Share

   
   
2. VERSTOCKT S, Schwarzler J, Willeit P, Bislenghi G, et al
   Identification of a druggable target that predicts postoperative Crohn's disease recurrence.
   Gastroenterology. 2026 Mar 16:S0016-5085(26)00233.
   

   >> Share

   
   
3. BUSKENS CJ, Bemelman WA
   Interpreting a Negative Trial in Complex Perianal Crohn's Disease: The End of Allogenic stem cell treatment for fistula patients?
   Gastroenterology. 2026 Mar 16:S0016-5085(26)00244.
   

   >> Share

   
   
4. KOTLARZ D
   Rewiring wound healing in Crohn's Disease - Fibroblast niches as the architects of fistula formation.
   Gastroenterology. 2026 Mar 10:S0016-5085(26)00206.
   

   >> Share

   
   
5. BRAUN T, Levhar N, Efroni G, Hadar R, et al
   Perturbations of Diet and Gut Signatures Persist During Remission in Crohn's Disease Despite Effective Immune Suppression.
   Gastroenterology. 2026 Mar 9:S0016-5085(25)06618.
   

   >> Share

   
   
6. NARULA N, Wong ECL, Rangarajan S, Miller V, et al
   Association Between Ultraprocessed Food Intake and Inflammatory Bowel Disease Risk: A Propensity-Matched Analysis With Monte Carlo Simulation From the Prospective Urban Rural Epidemiology Study.
   Gastroenterology. 2026 Mar 9:S0016-5085(25)06617.
   

   >> Share

   
   
7. COLOMBEL JF, Garcia Olmo D, Chen ST, Serclova Z, et al
   Darvadstrocel in Patients With Crohn's Disease With Complex Perianal Fistulas: The ADMIRE CD II Phase 3 Randomized Trial.
   Gastroenterology. 2026 Mar 6:S0016-5085(26)00024.
   

   >> Share

   
   February 2026
8. DUBOIS L, Chaussard A, Seksik P, Nancey S, et al
   Uncovering the dynamics of mucosa-associated microbiota in post-operative recurrence of Crohn's disease.
   Gastroenterology. 2026 Feb 24:S0016-5085(26)00147.
   

   >> Share

   
   
9. BOSSUYT P, Rahier JF, Baert F, Louis E, et al
   The effect of dose-intensification after secondary loss of response to ustekinumab in Crohn's disease: Results of the REScUE study.
   Gastroenterology. 2026 Feb 24:S0016-5085(26)00146.
   

   >> Share

   
   
10. BOURGONJE AR, Mian P
    Rethinking Infliximab Dosing in Acute Severe Ulcerative Colitis with Model-Informed Precision Dosing.
    Gastroenterology. 2026 Feb 23:S0016-5085(26)00152.
    

    >> Share

    
    
11. O'CONNOR G, Hazime H, Burgueno JF, Fernandez I, et al
    Quorum sensing molecules are elevated in long-standing ulcerative colitis and are linked to the development of colitis-associated cancer.
    Gastroenterology. 2026 Feb 11:S0016-5085(26)00090.
    

    >> Share

    
    
12. REINISCH W, Rittscher J, Iacucci M, Travis S, et al
    Toward Integration of Molecular Measures and Artificial Intelligence-Based Assessments With Clinical End Points in Inflammatory Bowel Disease.
    Gastroenterology. 2026 Feb 10:S0016-5085(25)06588.
    

    >> Share

    
    
13. VESTERGAARD MV, Allin KH, Nohr AK, Torresano Lominchar JV, et al
    Genetic Risk of Inflammatory Bowel Disease Is Associated With Disease Course Severity.
    Gastroenterology. 2026 Feb 10:S0016-5085(25)06019.
    

    >> Share

    
    
14. HASKEY N, Ye J, Lewis A, Yousuf M, et al
    Time-Restricted Feeding Reduces Body Mass Index, Visceral Adiposity, Systemic Inflammation, and Clinical Disease Activity in Adults With Crohn's Disease: A Randomized Controlled Study.
    Gastroenterology. 2026 Feb 9:S0016-5085(25)06485.
    

    >> Share

    
    
15. BEECHAM AH, McGovern DPB, Brugger SW, Davis MF, et al
    Genomic Insights Into Inflammatory Bowel Disease in United States Hispanic Participants: An Ancestry-Focused Study.
    Gastroenterology. 2026 Feb 9:S0016-5085(25)06484.
    

    >> Share

    
    
16. ARMET AM, Wine E
    Microbes and macrophages: how they interact to promote ulcerative colitis.
    Gastroenterology. 2026 Feb 3:S0016-5085(26)00092.
    

    >> Share

    
    
17. COHEN-MEKELBURG S, Hashash JG, Loftus EV Jr, Rubin DT, et al
    AGA Clinical Practice Update on Inpatient Management of Adults With Inflammatory Bowel Disease: Expert Review.
    Gastroenterology. 2026;170:408-417.
    

    >> Share

    
    January 2026
18. COWARD S, Brunet-Mas E, Burisch J, Lakatos PL, et al
    FORECASTING THE INCIDENCE AND PREVALENCE OF INFLAMMATORY BOWEL DISEASE ACROSS NINE EPIDEMIOLOGIC STAGE 3 NATIONS.
    Gastroenterology. 2026 Jan 30:S0016-5085(26)00032.
    

    >> Share

    
    
19. CHEN F
    Reconsidering the Microbiome and Maintenance Claims in Whole-Food Dietary Trials for Crohn's Disease.
    Gastroenterology. 2026 Jan 23:S0016-5085(26)00034.
    

    >> Share

    
    
20. YE Y, Yang J, Shang Y, Wang W, et al
    Dietary Flexibility as a Pathway to Nutritional Remission in Crohn's Disease.
    Gastroenterology. 2026 Jan 23:S0016-5085(26)00035.
    

    >> Share

    
    December 2025
21. LAMY-BESNIER Q, Theodorou I, Sokol H, De Paepe M, et al
    The Human Blood Virome Differs in Crohn's Disease.
    Gastroenterology. 2025 Dec 31:S0016-5085(25)06122.
    

    >> Share

    
    
22. RUDBAEK JJ, Koziol A, Fracchia A, Ernst M, et al
    Altered Metabolites at Birth in Individuals With Later Inflammatory Bowel Disease: A Danish Cohort Study.
    Gastroenterology. 2025 Dec 31:S0016-5085(25)06212.
    

    >> Share

    
    
23. PETER RIMMER, Zhang F, Scott G, Hold GL, et al
    The Gut Microbiome at the Onset of Inflammatory Bowel Disease: A Systematic Review and Unified Bioinformatic Synthesis.
    Gastroenterology. 2025 Dec 23:S0016-5085(25)06015.
    

    >> Share

    
    
24. LEE SH, Lopes EW, Khalili H, Croitoru K, et al
    Prediction and Prevention of Inflammatory Bowel Disease: A Call to Action.
    Gastroenterology. 2025 Dec 18:S0016-5085(25)06096.
    

    >> Share

    
    
25. THIAGARAJAH JR
    Tiptoeing in from the fatty fringes: mechanosensitive fibroblasts and Crohn's Disease.
    Gastroenterology. 2025 Dec 8:S0016-5085(25)06614.
    

    >> Share

    
    
26. SCOTT FI, Ananthakrishnan AN, Click B, Agrawal M, et al
    AGA Living Clinical Practice Guideline on the Pharmacologic Management of Moderate-to-Severe Crohn's Disease.
    Gastroenterology. 2025;169:1397-1448.
    

    >> Share

    
    November 2025
27. PAN L, Wang G
    Comments on the Role of TL1A/DR3 Signaling and Th9 Cells in Crohn's Disease.
    Gastroenterology. 2025 Nov 27:S0016-5085(25)06585.
    

    >> Share

    
    
28. JUKIC A, Hilbe R, Zundel L, Willeit P, et al
    Fecal Detection of Calprotectin Subunits Links Inflammatory Bowel Disease Activity With Chronicity of Intestinal Inflammation.
    Gastroenterology. 2025 Nov 26:S0016-5085(25)05987.
    

    >> Share

    
    
29. CHEN MY, Onal G, Mukherjee A, Ayati A, et al
    A Response to "Heavy Metals and Inflammatory Bowel Disease" Using Linked Sources of Real-World Data.
    Gastroenterology. 2025 Nov 21:S0016-5085(25)06576.
    

    >> Share

    
    
30. MARAFINI I, Salvatori S, Troncone E, Monteleone G, et al
    CD19 CAR T-Cell therapy for refractory ulcerative colitis.
    Gastroenterology. 2025 Nov 18:S0016-5085(25)06527.
    

    >> Share

    
    
31. GETTLER K, Nagpal S, Washburn S, Tastad C, et al
    Postoperative Ileum Transcriptomics Implicate Sex-Biased Mechanisms in Crohn's Disease Recurrence.
    Gastroenterology. 2025 Nov 18:S0016-5085(25)05983.
    

    >> Share

    
    
32. SHANG A, Wang W, Zhao K
    Artificial Intelligence in Inflammatory Bowel Disease Management.
    Gastroenterology. 2025 Nov 15:S0016-5085(25)06035.
    

    >> Share

    
    
33. BERNSTEIN CN, Gearry R, Nugent Z, Witt J, et al
    Global Discrepancies in Inflammatory Bowel Disease Care Reflect Health Care Expenditure Per Capita.
    Gastroenterology. 2025 Nov 14:S0016-5085(25)05902.
    

    >> Share

    
    
34. KUCHARZIK T, Allocca M, Torres J, Taylor SA, et al
    Role of Noninvasive Imaging in the Diagnosis and Management of Patients With Suspected and Established Inflammatory Bowel Disease.
    Gastroenterology. 2025;169:1166-1183.
    

    >> Share

    
    October 2025
35. TIAN Z, Huang Y
    Improving Precision in Crohn's Disease: Insights from the VCE Trial.
    Gastroenterology. 2025 Oct 29:S0016-5085(25)05894.
    

    >> Share

    
    
36. FAN Q, Li M
    Critical Role of Fucosyltransferase VII in Glycosylation-Dependent Regulatory T Cell Function in Inflammatory Bowel Disease.
    Gastroenterology. 2025 Oct 21:S0016-5085(25)06141.
    

    >> Share

    
    
37. SINGH S, Murad MH, Yuan Y, Ananthakrishnan AN, et al
    Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Crohn's Disease: 2025 AGA Evidence Synthesis.
    Gastroenterology. 2025 Oct 20:S0016-5085(25)05964.
    

    >> Share

    
    
38. DAI C, Huang YH
    Advancing Quiescent Crohn's Disease Management: Capsule Endoscopy-Guided Treat-to-Target Strategy or Standard Care?
    Gastroenterology. 2025 Oct 18:S0016-5085(25)05893.
    

    >> Share

    
    
39. WANG H, Xue K, Kong Y, Shen X, et al
    GRAVITI Study on Guselkumab's Efficacy and Safety for Moderate to Severe Crohn's Disease.
    Gastroenterology. 2025 Oct 10:S0016-5085(25)06110.
    

    >> Share

    
    
40. XU J, Gao Y, Zhang Y
    Subcutaneous IL-23 Blockade as a Patient-Centered Strategy in Crohn's Disease.
    Gastroenterology. 2025 Oct 10:S0016-5085(25)06111.
    

    >> Share

    
    
41. LIU J, Shi Y, Yang Y
    Reevaluating the GRAVITI Trial of Subcutaneous Guselkumab for Crohn's Disease.
    Gastroenterology. 2025 Oct 10:S0016-5085(25)06109.
    

    >> Share

    
    
42. IRWIN S, van Daelen M, Almaraz I, Park R, et al
    Fidaxomicin Reduces Collagen Expression in Intestinal Fibroblasts Via Platelet-Derived Growth Factor Receptor Beta and Glycogen Synthase Kinase-3 Beta Inhibition.
    Gastroenterology. 2025;169:925-941.
    

    >> Share

    
    
43. BOLTE LA, Bjork JR, Gacesa R, Weersma RK, et al
    Pharmacomicrobiomics: The Role of the Gut Microbiome in Immunomodulation and Cancer Therapy.
    Gastroenterology. 2025;169:813-827.
    

    >> Share

    
    September 2025
44. VAN LIEROP LMA, Devillers MJC, van der Woude CJ, Hoentjen F, et al
    Long-term outcomes of increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission: 3-year follow-up of the randomized controlled LADI trial.
    Gastroenterology. 2025 Sep 19:S0016-5085(25)06024.
    

    >> Share

    
    August 2025
45. MOULI VP, Kedia S, Sharma V, Pulimood AB, et al
    Navigating the Differential Diagnosis of Intestinal Tuberculosis and Crohn's Disease.
    Gastroenterology. 2025 Aug 19:S0016-5085(25)05883.
    

    >> Share

    
    
46. KHANNA R, Kuenzig ME
    Global Incidence and Prevalence of Inflammatory Bowel Disease Over Time.
    Gastroenterology. 2025 Aug 5:S0016-5085(25)05854.
    

    >> Share

    
    
47. HUANG S, Pan L, Pang S, Guo H, et al
    Perforin Generated by CD8(+) T Cells Exacerbates Inflammatory Bowel Disease-Induced Depression by Promoting CXCL9 Production in Intestinal Epithelial Cells.
    Gastroenterology. 2025;169:294-307.
    

    >> Share

    
    
48. STIDHAM RW, Ghanem LR, Fletcher JG, Bruining DH, et al
    Artificial Intelligence-Enabled Clinical Trials in Inflammatory Bowel Disease: Automating and Enhancing Disease Assessment and Study Management.
    Gastroenterology. 2025;169:432-443.
    

    >> Share

    
    July 2025
49. LI WAI SUEN CFD, Choy MC, Con D, Cheng K, et al
    Early infliximab levels and clearance predict outcomes after infliximab rescue in acute severe ulcerative colitis: Results from PREDICT-UC.
    Gastroenterology. 2025 Jul 21:S0016-5085(25)05777.
    

    >> Share

    
    
50. BOURGONJE AR, Ibing S, Rajauria P, Peraza J, et al
    Mild Crohn's Disease is Associated with Altered Sphingolipid Metabolism and Reduced Neutrophilic Inflammation.
    Gastroenterology. 2025 Jul 7:S0016-5085(25)05731.
    

    >> Share

    
    
51. REZAZADEH ARDABILI A, Polydorides AD, Colombel JF
    Scrotal swelling in a patient with Crohn's disease: More than meets the eye.
    Gastroenterology. 2025 Jul 2:S0016-5085(25)05728.
    

    >> Share

    
    June 2025
52. BEMELMAN WA, Haanappel AEG, Duijvestein M, van der Does de Willebois EML, et al
    Comments on "Postoperative Endoscopic Outcomes in the MESOCOLIC Trial Investigating Mesenteric-Based Surgery for Crohn's Disease".
    Gastroenterology. 2025 Jun 30:S0016-5085(25)00955.
    

    >> Share

    
    
53. LIU D, Wei Y, Wan J
    Exploring the Role of Wearable Devices in Inflammatory Bowel Disease Management.
    Gastroenterology. 2025 Jun 25:S0016-5085(25)00906.
    

    >> Share

    
    
54. WANG P, Wang J, Zhang P, Xiao W, et al
    Comments on "Preclinical protein signatures of Crohn's disease and ulcerative colitis: A nested case-control study within large population-based cohorts".
    Gastroenterology. 2025 Jun 23:S0016-5085(25)00903.
    

    >> Share

    
    
55. FRUTKOFF YA, Plotkin L, Pollak D, Livovsky J, et al
    Whole food diet induces remission in children and young adults with mild-moderate Crohn's disease and is more tolerable than exclusive enteral nutrition: a randomized controlled trial.
    Gastroenterology. 2025 Jun 17:S0016-5085(25)00896.
    

    >> Share

    
    May 2025
56. HANZEL J, Solitano V, Vuyyuru SK, Panaccione R, et al
    An International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel Disease.
    Gastroenterology. 2025 May 28:S0016-5085(25)00825.
    

    >> Share

    
    
57. ZHANG Y, Ran Q, Tang X, Wang Y, et al
    Creeping Fat and Muscle Hyperplasia in Crohn's Disease: A Critical Mechanistic Link for Stricture Formation.
    Gastroenterology. 2025 May 2:S0016-5085(25)00665.
    

    >> Share

    
    
58. KELM M, Flemming S
    The importance of the mesentery in the pathophysiology of Crohn's disease.
    Gastroenterology. 2025 May 2:S0016-5085(25)00664.
    

    >> Share

    
    April 2025
59. WU X, Li Y, Li P, Lu G, et al
    Structural variations in ulcerative colitis-associated E. coli reduce fructose utilization and aggravate inflammation under high fructose diet.
    Gastroenterology. 2025 Apr 16:S0016-5085(25)00635.
    

    >> Share

    
    
60. ALLOCCA M, Falloon K, Danese S, Rieder F, et al
    Monitoring the calm before the storm - A video capsule endoscopy guided proactive treat-to-target approach in Crohn's disease.
    Gastroenterology. 2025 Apr 10:S0016-5085(25)00631.
    

    >> Share

    
    
61. MENGHINI P, Butto LF, Gomez-Nguyen A, Aladyshkina N, et al
    TL1A/DR3 signaling regulates the generation of pathogenic Th9 cells in experimental Crohn's disease.
    Gastroenterology. 2025 Apr 7:S0016-5085(25)00606.
    

    >> Share

    
    
62. LIU K, Chen B, Lin X, Zhou Q, et al
    alpha1,3 Fucosyltransferase VII Improves Intestinal Immune Homeostasis in Inflammatory Bowel Disease by Enhancing Regulatory T-Cell Intestinal Homing and Immunosuppression.
    Gastroenterology. 2025 Apr 1:S0016-5085(25)00586.
    

    >> Share

    
    March 2025
63. LI L
    Impact of Parental Crohn's Disease on Offspring's Gut Health and Disease Vulnerability.
    Gastroenterology. 2025 Mar 31:S0016-5085(25)00588.
    

    >> Share

    
    
64. TANG L
    Comments on "Multimodal Profiling of Peripheral Blood Identifies Proliferating Circulating Effector CD4+ T Cells as Predictors for Response to Integrin alpha4beta7-Blocking Therapy in Inflammatory Bowel Disease".
    Gastroenterology. 2025 Mar 28:S0016-5085(25)00545.
    

    >> Share

    
    
65. NARVEY S, Ghia JE, Marrie RA, Armstrong H, et al
    Heavy Metals and Inflammatory Bowel Disease.
    Gastroenterology. 2025 Mar 27:S0016-5085(25)00540.
    

    >> Share

    
    
66. PRENTICE RE, Flanagan EK, Wright EK, Dolinger MT, et al
    Active inflammatory bowel disease on intestinal ultrasound during pregnancy is associated with an increased risk of adverse pregnancy and neonatal outcomes independent of clinical and biochemical disease activity.
    Gastroenterology. 2025 Mar 25:S0016-5085(25)00537.
    

    >> Share

    
    
67. MCDONALD BD, Choi NK, Klein JA, St-Pierre J, et al
    Clinical trials for perianal Crohn's disease: A call for a revised approach.
    Gastroenterology. 2025 Mar 20:S0016-5085(25)00529.
    

    >> Share

    
    
68. HART A, Panaccione R, Steinwurz F, Danese S, et al
    Efficacy and Safety of Guselkumab Subcutaneous Induction and Maintenance in Participants with Moderately to Severely Active Crohn's Disease: Results from the Phase 3 GRAVITI Study.
    Gastroenterology. 2025 Mar 18:S0016-5085(25)00522.
    

    >> Share

    
    
69. BEN-HORIN S, Lahat A, Ungar B, Ukashi O, et al
    Capsule endoscopy-guided proactive treat-to-target versus continued standard care in patients with quiescent Crohn's disease: A randomized controlled trial.
    Gastroenterology. 2025 Mar 13:S0016-5085(25)00519.
    

    >> Share

    
    
70. IACUCCI M, Santacroce G, Maeda Y, Ghosh S, et al
    AI-driven Personalized Medicine: Transforming Clinical Practice in Inflammatory Bowel Disease.
    Gastroenterology. 2025 Mar 10:S0016-5085(25)00494.
    

    >> Share

    
    
71. WANG Y, Zhang C
    Expand Research in Risk of Developing Crohn's Disease.
    Gastroenterology. 2025 Mar 6:S0016-5085(25)00490.
    

    >> Share

    
    
72. YANG X, Hu Q
    Comments on "Healthy first-degree relatives from multiplex families versus simplex families have a higher subclinical intestinal inflammation, a distinct fecal microbial signature, and harbor a higher risk of developing Crohn's disease".
    Gastroenterology. 2025 Mar 6:S0016-5085(25)00489.
    

    >> Share

    
    February 2025
73. NANDY A, Petralia F, Porter C, Elledge S, et al
    Epstein-Barr Virus (EBV) Exposure Precedes Crohn;s Disease Development.
    Gastroenterology. 2025 Feb 21:S0016-5085(25)00411.
    

    >> Share

    
    
74. ABREU MT, Devkota S, Issokson K
    A Mediterranean diet for Crohn's disease: Embracing colorful diversity to improve the microbiome.
    Gastroenterology. 2025 Feb 14:S0016-5085(25)00366.
    

    >> Share

    
    
75. MA C
    Mirikizumab for Crohn's Disease: Small Step Forward or Giant Leap Ahead?
    Gastroenterology. 2025 Feb 4:S0016-5085(25)00344.
    

    >> Share

    
    
76. TURPIN W, Lee SH, Croitoru K
    Gut Microbiome Signature in Predisease Phase of Inflammatory Bowel Disease: Prediction to Pathogenesis to Prevention.
    Gastroenterology. 2025 Feb 3:S0016-5085(25)00039.
    

    >> Share

    
    January 2025
77. KHANNA R
    The safety and efficacy of guselkumab for the treatment of moderate to severely active ulcerative colitis.
    Gastroenterology. 2025 Jan 31:S0016-5085(25)00333.
    

    >> Share

    
    
78. OWEN C, Shen L, Cardoso A, Lichenstein G, et al
    Comments on biologic ranking methodology used by the network meta-analysis to inform the 2024 ulcerative colitis guideline.
    Gastroenterology. 2025 Jan 25:S0016-5085(25)00062.
    

    >> Share

    
    
79. LI L
    Pouch Crohn's-like Disease: Mucosal Single-Cell Profiling Uncovers Pathogenesis and Targets.
    Gastroenterology. 2025 Jan 17:S0016-5085(25)00045.
    

    >> Share

    
    
80. GODNY L, Elial-Fatal S, Arrouasse J, Sharar Fischler T, et al
    Mechanistic implications of the Mediterranean diet in patients with newly diagnosed Crohn's disease- multi-omic results from a prospective cohort.
    Gastroenterology. 2025 Jan 13:S0016-5085(25)00038.
    

    >> Share

    
    
81. DUAN M, Liu W, Coffey JC, Ke J, et al
    Postoperative Endoscopic Outcomes in the MESOCOLIC Trial Investigating Mesenteric-based surgery for Crohn's Disease.
    Gastroenterology. 2025 Jan 9:S0016-5085(25)00017.
    

    >> Share

    
    
82. HIRTEN RP, Danieletto M, Sanchez-Mayor M, Whang JK, et al
    Physiological Data Collected from Wearable Devices Identify and Predict Inflammatory Bowel Disease Flares.
    Gastroenterology. 2025 Jan 9:S0016-5085(25)00013.
    

    >> Share

    
    December 2024
83. COFFEY JC, Bai L, Wu FF
    Catching up with creeping fat - unravelling the mysteries of the mesentery in Crohn's disease.
    Gastroenterology. 2024 Dec 24:S0016-5085(24)05805.
    

    >> Share

    
    
84. LI L
    Comments on "Inflammatory markers at birth and risk of early onset inflammatory bowel disease".
    Gastroenterology. 2024 Dec 20:S0016-5085(24)05797.
    

    >> Share

    
    
85. SHAO X, Chen J, Zhu C, Li J, et al
    Analysis of "Inflammatory Markers at Birth and Risk of Early-Onset Inflammatory Bowel Disease".
    Gastroenterology. 2024 Dec 20:S0016-5085(24)05795.
    

    >> Share

    
    
86. MAO XY, Yang YY, Tian L
    A win-win solution: remarkable reversal of foot necrosis in ulcerative colitis.
    Gastroenterology. 2024 Dec 7:S0016-5085(24)05784.
    

    >> Share

    
    
87. SINGH S, Loftus EV Jr, Limketkai BN, Haydek JP, et al
    AGA Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe Ulcerative Colitis.
    Gastroenterology. 2024;167:1307-1343.
    

    >> Share

    
    
88. DI VINCENZO F, Quintero MA, Mendygral P, Abreu MT, et al
    Gender Inequity in Pharma-Supported Inflammatory Bowel Disease Presentations: Shining a Light on Opportunities for Equality and Transparency in Medical Research.
    Gastroenterology. 2024;167:1256-1259.
    

    >> Share

    
    
89. ZHAO Q, Duck LW, Killian JT Jr, Rosenberg AF, et al
    Crohn's Patients and Healthy Infants Share Immunodominant B Cell Response to Commensal Flagellin Peptide Epitopes.
    Gastroenterology. 2024;167:1415-1428.
    

    >> Share

    
    November 2024
90. GRANNO O, Bergemalm D, Salomon B, Lindqvist CM, et al
    Preclinical protein signatures of Crohn's disease and ulcerative colitis: A nested case-control study within large population-based cohorts.
    Gastroenterology. 2024 Nov 21:S0016-5085(24)05741.
    

    >> Share

    
    
91. KAPPELMAN MD, Brensinger C, Parlett LE, Hurtado-Lorenzo A, et al
    Prevalence of Pediatric Inflammatory Bowel Disease in the United States: Pooled Estimates from Three Administrative Claims Data Sources.
    Gastroenterology. 2024 Nov 16:S0016-5085(24)05698.
    

    >> Share

    
    
92. AGRAWAL M, Ungaro RC, Rajauria P, Magee J, et al
    High serum pesticide levels are associated with increased odds of inflammatory bowel disease in a nested case-control study.
    Gastroenterology. 2024 Nov 9:S0016-5085(24)05692.
    

    >> Share

    
    
93. LIU W, Mao R, Nga Le TH, West G, et al
    CREEPING FAT-DERIVED FREE FATTY ACIDS INDUCE HYPERPLASIA OF INTESTINAL MUSCULARIS PROPRIA MUSCLE CELLS - A NOVEL LINK BETWEEN FAT AND INTESTINAL STRICTURE FORMATION IN CROHN'S DISEASE.
    Gastroenterology. 2024 Nov 8:S0016-5085(24)05659.
    

    >> Share

    
    
94. DORNER H, Stolzer I, Mattner J, Kaminski S, et al
    Gut Pathobiont-Derived Outer Membrane Vesicles Drive Liver Inflammation and Fibrosis in Primary Sclerosing Cholangitis-Associated Inflammatory Bowel Disease.
    Gastroenterology. 2024;167:1183-1197.
    

    >> Share

    
    October 2024
95. JONES K, Plotkin L, Loukogeorgakis S, Cytter-Kuint R, et al
    The management of internal fistulizing Crohn's disease in a child: more than meets the eye.
    Gastroenterology. 2024 Oct 28:S0016-5085(24)05644.
    

    >> Share

    
    
96. ANANTHAKRISHNAN AN, Murad MH, Scott FI, Agrawal M, et al
    Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Ulcerative Colitis: 2024 American Gastroenterological Association Evidence Synthesis.
    Gastroenterology. 2024 Oct 18:S0016-5085(24)05480.
    

    >> Share

    
    
97. SOLITANO V, Hogan M, Singh S, Danese S, et al
    Placebo rates in Crohn's disease randomized clinical trials: An individual patient data meta-analysis.
    Gastroenterology. 2024 Oct 14:S0016-5085(24)05571.
    

    >> Share

    
    
98. LEE SH, Bushra M, Qiu L, Griffiths AM, et al
    Early Life Exposure to Parental Crohn's disease is Associated with Offspring's Gut Microbiome, Gut Permeability and Increased Risk of Future Crohn's Disease.
    Gastroenterology. 2024 Oct 7:S0016-5085(24)05539.
    

    >> Share

    
    
99. CAMILLERI M
    Pouchitis: Is It Time to Think Beyond the Inflammation in the Pouch?
    Gastroenterology. 2024;167:821-825.
    

    >> Share

    
    September 2024
100. HORN V, Cancino CA, Steinheuer LM, Obermayer B, et al
     Multimodal profiling of peripheral blood identifies proliferating circulating effector CD4(+) T cells as predictors for response to integrin alpha4beta7-blocking therapy in inflammatory bowel disease.
     Gastroenterology. 2024 Sep 27:S0016-5085(24)05527.
     

     >> Share

     
     
101. ROSHANOV PS, Khanna R
     Risankizumab for Induction and Maintenance of Remission in Ulcerative Colitis.
     Gastroenterology. 2024 Sep 7:S0016-5085(24)05444.
     

     >> Share

     
     
102. ROSHANOV PS, Khanna R
     A Head-to Head Comparison of Risankizumab and Ustekinumab as second line therapy in moderate to severely active Crohn's disease.
     Gastroenterology. 2024 Sep 7:S0016-5085(24)05445.
     

     >> Share

     
     
103. OLIVERA PA, Martinez-Lozano H, Leibovitzh H, Xue M, et al
     Healthy first-degree relatives from multiplex families versus simplex families have a higher subclinical intestinal inflammation, a distinct fecal microbial signature, and harbor a higher risk of developing Crohn's disease.
     Gastroenterology. 2024 Sep 3:S0016-5085(24)05414.
     

     >> Share

     
     August 2024
104. LU C, Feagan BG, Fletcher JG, Baker M, et al
     Management of Small Bowel Crohn's Disease Strictures: To cut, to stretch or to treat inflammation?
     Gastroenterology. 2024 Aug 31:S0016-5085(24)05413.
     

     >> Share

     
     
105. LEE SH, Turpin W, Espin-Garcia O, Xu W, et al
     Development and Validation of an Integrative Risk Score for Future Risk of Crohn's Disease in Healthy First-Degree Relatives: A Multicentre Prospective Cohort Study.
     Gastroenterology. 2024 Aug 27:S0016-5085(24)05401.
     

     >> Share

     
     
106. KAHN-BOESEL O, Araka E, Anyane-Yeboa A, Ufere NN, et al
     The Discrepant Visual Representation of Inflammatory Bowel Diseases in the Internet and Media.
     Gastroenterology. 2024;167:436-440.
     

     >> Share

     
     
107. LUO X, Wang J, Tan C, Dou Q, et al
     Rapid Endoscopic Diagnosis of Benign Ulcerative Colorectal Diseases With an Artificial Intelligence Contextual Framework.
     Gastroenterology. 2024;167:591-603.
     

     >> Share

     
     July 2024
108. CAO S, Nguyen K, Ma K, Du X, et al
     Mucosal Single-Cell Profiling of Crohn's-Like Disease of the Pouch Reveals Unique Pathogenesis and Therapeutic Targets.
     Gastroenterology. 2024 Jul 29:S0016-5085(24)05284.
     

     >> Share

     
     
109. GAWEY BJ, Kane SV
     Head and Neck Pain in a Patient with Ulcerative Colitis.
     Gastroenterology. 2024 Jul 27:S0016-5085(24)05285.
     

     >> Share

     
     
110. RUDBAEK JJ, Borbye-Lorenzen N, Poulsen GJ, Koziol A, et al
     Inflammatory markers at birth and risk of early onset inflammatory bowel disease.
     Gastroenterology. 2024 Jul 13:S0016-5085(24)05210.
     

     >> Share

     
     
111. MULANAX C, Velayos FS
     Shot heard around the world? Subcutaneous Infliximab (CT-P13) as Maintenance Therapy for Inflammatory Bowel Disease.
     Gastroenterology. 2024 Jul 11:S0016-5085(24)05207.
     

     >> Share

     
     
112. ASHTON JJ, Satsangi J, Uhlig HH
     Intestinal Inflammation and Extraintestinal Disease: Understanding Dynamic Risk.
     Gastroenterology. 2024;167:205-208.
     

     >> Share

     
     June 2024
113. PEDICELLI A, Michel RP, Sebastiani G
     An Unusual Cause of Acute Liver Failure Diagnosed on Organ Explant in a Patient with Ulcerative Colitis.
     Gastroenterology. 2024 Jun 29:S0016-5085(24)05174.
     

     >> Share

     
     
114. BOURGONJE AR, Ungaro RC, Mehandru S, Colombel JF, et al
     Targeting the IL-23 Pathway in Inflammatory Bowel Disease.
     Gastroenterology. 2024 Jun 28:S0016-5085(24)05124.
     

     >> Share

     
     May 2024
115. HANAUER SB, Sands BE, Schreiber S, Danese S, et al
     Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Inflammatory Bowel Disease: Two Randomized Phase 3 Trials.
     Gastroenterology. 2024 May 22:S0016-5085(24)04918.
     

     >> Share

     
     
116. LUJAN R, Buchuk R, Focht G, Yogev D, et al
     Early Initiation of Biologics and Disease Outcomes in Adults and Children With Inflammatory Bowel Diseases: Results From the Epidemiology Group of the Nationwide Israeli Inflammatory Bowel Disease Research Nucleus Cohort.
     Gastroenterology. 2024;166:815-825.
     

     >> Share

     
     
117. BAMIDELE AO, Mishra SK, Piovezani Ramos G, Hirsova P, et al
     Interleukin 21 Drives a Hypermetabolic State and CD4(+) T-Cell-Associated Pathogenicity in Chronic Intestinal Inflammation.
     Gastroenterology. 2024;166:826-841.
     

     >> Share

     
     April 2024
118. HONAP S, Sands BE, Jairath V, Danese S, et al
     Basket, Umbrella, and Platform Trials: The Potential for Master Protocol -Based Trials in Inflammatory Bowel Disease.
     Gastroenterology. 2024 Apr 25:S0016-5085(24)00485.
     

     >> Share

     
     
119. KEEFER L, Hashash JG, Szigethy E, Mayer EA, et al
     AGA Clinical Practice Update on Pain Management in Inflammatory Bowel Disease: Commentary.
     Gastroenterology. 2024 Apr 17:S0016-5085(24)00358.
     

     >> Share

     
     
120. ZOLLNER A, Koch R, Jukic A, Pfister A, et al
     Clearance of gut mucosal SARS-CoV-2 antigens and post-acute COVID-19 after two years in patients with inflammatory bowel disease.
     Gastroenterology. 2024 Apr 15:S0016-5085(24)00423.
     

     >> Share

     
     March 2024
121. IACUCCI M, Maeda Y, Ghosh S
     A Baby Step or a Real Giant Stride: Histomic Enabled by Artificial Intelligence to Predict Treatment Response in Pediatric Patients with Ulcerative Colitis.
     Gastroenterology. 2024 Mar 7:S0016-5085(24)00284.
     

     >> Share

     
     
122. ZINGONE F, Bai JC, Cellier C, Ludvigsson JF, et al
     Celiac disease-related conditions: Who to test?
     Gastroenterology. 2024 Mar 7:S0016-5085(24)00282.
     

     >> Share

     
     
123. MITEV S, Marinova C, Spassova Z
     A colorful conundrum: dark urine in a patient with inflammatory bowel disease.
     Gastroenterology. 2024 Mar 5:S0016-5085(24)00249.
     

     >> Share

     
     
124. PEERY AF, Kelly CR, Kao D, Vaughn BP, et al
     AGA Clinical Practice Guideline on Fecal Microbiota-Based Therapies for Select Gastrointestinal Diseases.
     Gastroenterology. 2024;166:409-434.
     

     >> Share

     
     
125. DULAI PS, Singh S, Jairath V, Wong E, et al
     Integrating Evidence to Guide Use of Biologics and Small Molecules for Inflammatory Bowel Diseases.
     Gastroenterology. 2024;166:396-408.
     

     >> Share

     
     February 2024
126. KHROM M, Long M, Dube S, Robbins L, et al
     Comprehensive association analyses of extraintestinal manifestations in inflammatory bowel disease.
     Gastroenterology. 2024 Feb 27:S0016-5085(24)00232.
     

     >> Share

     
     
127. HERAUF M, Coward S, Pena-Sanchez JN, Bernstein CN, et al
     A Commentary on the Epidemiology of Inflammatory Bowel Disease in Compounding Prevalence Nations: Towards Sustaining Healthcare Delivery.
     Gastroenterology. 2024 Feb 18:S0016-5085(24)00178.
     

     >> Share

     
     
128. MARILD K, Soderling J, Stephansson O, Axelrad J, et al
     Histological remission in inflammatory bowel disease and female fertility: A nationwide study.
     Gastroenterology. 2024 Feb 6:S0016-5085(24)00055.
     

     >> Share

     
     
129. KOCHAR B, Ananthakrishnan AN, Ritchie CS
     Pharmacoequity for Older Adults With Inflammatory Bowel Diseases.
     Gastroenterology. 2024;166:235-239.
     

     >> Share

     
     
130. HE S, Peng Y, Wei Q
     Comments on "Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation Study".
     Gastroenterology. 2024;166:356-357.
     

     >> Share

     
     
131. LIU X, Prasath S, Siddiqui I, Walters TD, et al
     Machine Learning-Based Prediction of Pediatric Ulcerative Colitis Treatment Response using Diagnostic Histopathology.
     Gastroenterology. 2024 Feb 1:S0016-5085(24)00119.
     

     >> Share

     
     January 2024
132. HASHASH JG, Elkins J, Lewis JD, Binion DG, et al
     AGA Clinical Practice Update on Diet and Nutritional Therapies in Patients With Inflammatory Bowel Disease: Expert Review.
     Gastroenterology. 2024 Jan 23:S0016-5085(23)05597.
     

     >> Share

     
     
133. KOSINSKY RL, Gonzalez MM, Saul D, Barros LL, et al
     The FOXP3(+) Pro-inflammatory T cell: A Potential Therapeutic Target in Crohn's Disease.
     Gastroenterology. 2024 Jan 9:S0016-5085(24)00009.
     

     >> Share

     
     
134. BARNES EL, Agrawal M, Syal G, Ananthakrishnan AN, et al
     AGA Clinical Practice Guideline on the Management of Pouchitis and Inflammatory Pouch Disorders.
     Gastroenterology. 2024;166:59-85.
     

     >> Share

     
     
135. GILLILAND A, Chan JJ, De Wolfe TJ, Yang H, et al
     Pathobionts in Inflammatory Bowel Disease: Origins, Underlying Mechanisms, and Implications for Clinical Care.
     Gastroenterology. 2024;166:44-58.
     

     >> Share

     
     
136. EQUINOZZI E, O'Donnell M, Lee CD
     A Woman With Pyoderma Gangrenosum, Recurrent Abdominal Pain, and Hematochezia.
     Gastroenterology. 2024;166:31-35.
     

     >> Share

     
     
137. SHEN X, Zhang Q, Zhang B
     A 16-Year-Old Onset Case of Pancolitis With Rectovaginal and Rectovesical Fistulas.
     Gastroenterology. 2024;166:e1-e5.
     

     >> Share

     
     December 2023
138. CAENEPEEL C, Falony G, Machiels K, Verstockt B, et al
     Dysbiosis and associated stool features improve prediction of response to biological therapy in inflammatory bowel disease.
     Gastroenterology. 2023 Dec 12:S0016-5085(23)05598.
     

     >> Share

     
     
139. ANANTHAKRISHNAN AN, Adler J, Chachu KA, Nguyen NH, et al
     AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Crohn's Disease.
     Gastroenterology. 2023;165:1367-1399.
     

     >> Share

     
     
140. SEGAL JP
     Vedolizumab Earning Its Place as a Treatment for Chronic Pouchitis.
     Gastroenterology. 2023;165:1574-1575.
     

     >> Share

     
     November 2023
141. KOTLARZ DANIEL
     Unveiling the protective role of BTNL-selected gammadelta T cells in inflammatory bowel disease.
     Gastroenterology. 2023 Nov 28:S0016-5085(23)05566.
     

     >> Share

     
     
142. DAVE M, Luther J, Briggs F
     Time to Include Inflammatory Bowel Disease as a Notifiable Disease?
     Gastroenterology. 2023 Nov 7:S0016-5085(23)05223.
     

     >> Share

     
     
143. WINE E
     Could gut and food-derived yeast be responsible for activating T-cells in Crohn disease?
     Gastroenterology. 2023 Nov 3:S0016-5085(23)05204.
     

     >> Share

     
     
144. VENKATESWARAN N
     Mirikizumab for the Management of Ulcerative Colitis.
     Gastroenterology. 2023 Nov 3:S0016-5085(23)05206.
     

     >> Share

     
     October 2023
145. LEE HH, Singh S
     Quantifying Endoscopic Activity in Ulcerative Colitis: Innovation, Powered by AI.
     Gastroenterology. 2023 Oct 30:S0016-5085(23)05201.
     

     >> Share

     
     
146. STIDHAM RW, Cai L, Cheng S, Rajaei F, et al
     Using Computer Vision to Improve Endoscopic Disease Quantification in Therapeutic Clinical Trials of Ulcerative Colitis.
     Gastroenterology. 2023 Oct 11:S0016-5085(23)05086.
     

     >> Share

     
     
147. YARUR AJ, Bruss A, Moosreiner A, Beniwal-Patel P, et al
     Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation Study.
     Gastroenterology. 2023;165:963-975.
     

     >> Share

     
     September 2023
148. CHEN J, Yang Q, Wang C
     Multiple Hepatic Masses in a Patient with Crohn's disease.
     Gastroenterology. 2023 Sep 20:S0016-5085(23)05014.
     

     >> Share

     
     
149. KHANNA R
     Upadacitinib for the Treatment of Crohn's Disease.
     Gastroenterology. 2023 Sep 13:S0016-5085(23)05001.
     

     >> Share

     
     
150. GANAPATHY A, Navale P, Mutch MG, Kim H, et al
     Long-Standing Symptomatic Fistulizing Perianal Crohn's Disease: Progression beyond inflammation.
     Gastroenterology. 2023 Sep 12:S0016-5085(23)04997.
     

     >> Share

     
     
151. LI Z, Chen Y, Ke H
     Investigating the Causal Relationship between Gut Microbiota and Crohn's Disease: A Mendelian Randomization Study.
     Gastroenterology. 2023 Sep 5:S0016-5085(23)04972.
     

     >> Share

     
     
152. HUANG J, Chan SC, Fung YC, Mak FY, et al
     Incidence, Risk Factors, and Temporal Trends of Small Intestinal Cancer: A Global Analysis of Cancer Registries.
     Gastroenterology. 2023;165:600-612.
     

     >> Share

     
     
153. WINE E
     Pharmacomicrobiomics in IBD: Should We Select Treatments Based on Gut Microbes?
     Gastroenterology. 2023;165:802-803.
     

     >> Share

     
     August 2023
154. PEYRIN-BIROULET L, Allegretti JR, Rubin DT, Bressler B, et al
     Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study.
     Gastroenterology. 2023 Aug 31:S0016-5085(23)04963.
     

     >> Share

     
     
155. LELEIKO NS
     Comment Regarding "Comparative Effectiveness of Anti-TNF in Combination With Low-Dose Methotrexate vs Anti-TNF Monotherapy in Pediatric Crohn's Disease: A Pragmatic Randomized Trial".
     Gastroenterology. 2023 Aug 7:S0016-5085(23)04882.
     

     >> Share

     
     
156. KELM M, Flemming S
     Surgical Resection Might Be the Preferred Therapy Option in Ileocecal Crohn's Disease.
     Gastroenterology. 2023 Aug 4:S0016-5085(23)04840.
     

     >> Share

     
     
157. DAMAS OM, Maldonado-Contreras A
     Breaking Barriers in Dietary Research: Strategies to Diversify Recruitment in Clinical Studies and Develop Culturally Tailored Diets for Hispanic Communities Living With Inflammatory Bowel Disease.
     Gastroenterology. 2023;165:324-328.
     

     >> Share

     
     July 2023
158. MUKHERJEE PK, Nguyen QT, Li J, Zhao S, et al
     Stricturing Crohn's disease single-cell RNA sequencing reveals fibroblast heterogeneity and intercellular interactions.
     Gastroenterology. 2023 Jul 26:S0016-5085(23)04788.
     

     >> Share

     
     
159. LEWIS JD, Parlett LE, Jonsson-Funk ML, Brensinger C, et al
     Incidence, Prevalence and Racial and Ethnic Distribution of Inflammatory Bowel Disease in the United States.
     Gastroenterology. 2023 Jul 15:S0016-5085(23)04776.
     

     >> Share

     
     
160. BAUMDICK ME, Niehrs A, Degenhardt F, Schwerk M, et al
     HLA-DP on Epithelial Cells enables Tissue Damage by NKp44(+) NK Cells in Ulcerative Colitis.
     Gastroenterology. 2023 Jul 14:S0016-5085(23)04772.
     

     >> Share

     
     
161. YAN F, Yang Y
     First line treatment options for ileocecal Crohn's disease: Early surgical resection or Biologics?
     Gastroenterology. 2023 Jul 3:S0016-5085(23)00933.
     

     >> Share

     
     
162. DEEPAK P, Barnes EL, Shaukat A
     Health Disparities in Inflammatory Bowel Disease Care Driven by Rural Versus Urban Residence: Challenges and Potential Solutions.
     Gastroenterology. 2023;165:11-15.
     

     >> Share

     
     
163. GHUSN W, Acosta A, Kane S
     An Unusual Etiology of Bleeding in an Inflammatory Bowel Disease Surveillance Colonoscopy.
     Gastroenterology. 2023;165:40-43.
     

     >> Share

     
     June 2023
164. GAO S, Zhu R, Zhu L
     Toward the understanding of altered gut microbiome in Crohn's disease: cause or consequence.
     Gastroenterology. 2023 Jun 23:S0016-5085(23)00883.
     

     >> Share

     
     
165. AGRAWAL M, Ebert AC, Poulsen G, Ungaro RC, et al
     Early ileocecal resection for Crohn's disease is associated with improved long-term outcomes compared to anti-tumor necrosis factor therapy: a population-based cohort study.
     Gastroenterology. 2023 Jun 9:S0016-5085(23)00872.
     

     >> Share

     
     
166. HE S, Lei P, Kang W, Cheung P, et al
     Stiffness Restricts the Stemness of the Intestinal Stem Cells and Skews Their Differentiation Toward Goblet Cells.
     Gastroenterology. 2023;164:1137-1151.
     

     >> Share

     
     
167. ROSHANOV PS, Khanna R
     Continuation of Tumor Necrosis Factor Antagonists for Inflammatory Bowel Diseases During Pregnancy.
     Gastroenterology. 2023;164:1336-1337.
     

     >> Share

     
     
168. KILINCALP S, Mottacki N
     A Shallow Large Ulcer on the Ileocecal Valve in a Young Man With Ulcerative Proctitis.
     Gastroenterology. 2023;164:e16-e18.
     

     >> Share

     
     May 2023
169. RAYGOZA GARAY JA, Turpin W, Lee SH, Smith MI, et al
     Gut Microbiome Composition is associated with future onset of Crohn's Disease in Healthy First-Degree Relatives.
     Gastroenterology. 2023 May 30:S0016-5085(23)00805.
     

     >> Share

     
     
170. GHONEIM S
     Etrasimod in ulcerative colitis.
     Gastroenterology. 2023 May 11:S0016-5085(23)00725.
     

     >> Share

     
     
171. ARMSTRONG H, Sigall-Boneh R, Wine E
     This Letter to the Editor is in response to: Microbial Riboflavin Biosynthesis Associates with Response to Dietary Fiber Consumption: Time to Personalize Adjunct Therapy in Patients with Inflammatory Bowel Disease?
     Gastroenterology. 2023 May 5:S0016-5085(23)00700.
     

     >> Share

     
     
172. NEWMAN KL, Chedid VG, Boden EK
     A Systematic Review of Inflammatory Bowel Disease Epidemiology and Health Outcomes in Sexual and Gender Minority Individuals.
     Gastroenterology. 2023;164:866-871.
     

     >> Share

     
     April 2023
173. NOBLE AJ, Nowak JK, Adams AT, Uhlig HH, et al
     Defining interactions between the genome, epigenome, and the environment in inflammatory bowel disease: progress and prospects.
     Gastroenterology. 2023 Apr 14:S0016-5085(23)00619.
     

     >> Share

     
     
174. D'HAENS GR, Lee S, Taylor SA, Serone A, et al
     Filgotinib for the Treatment of Small Bowel Crohn's Disease: the DIVERGENCE 1 Trial.
     Gastroenterology. 2023 Apr 11:S0016-5085(23)00591.
     

     >> Share

     
     
175. ALLEGRETTI JR, Mitsialis V, Canavan JB, Snapper SB, et al
     Low-dose IL-2 for the Treatment of Moderate to Severe Ulcerative Colitis.
     Gastroenterology. 2023 Apr 6:S0016-5085(23)00584.
     

     >> Share

     
     
176. FRAISSENON A, Desmurs-Clavel H, Guibaud L
     Severe Chronic Rectocolitis Associated With a Characteristic Sunflower Magnetic Resonance Imaging Pattern.
     Gastroenterology. 2023;164:529-532.
     

     >> Share

     
     
177. GOWEN R, Gamal A, Di Martino L, McCormick TS, et al
     Modulating the Microbiome for Crohn's Disease Treatment.
     Gastroenterology. 2023;164:828-840.
     

     >> Share

     
     March 2023
178. KAPPELMAN MD, Wohl DA, Herfarth HH, Firestine AM, et al
     Comparative Effectiveness of Anti-TNF in Combination with Low Dose Methotrexate vs Anti-TNF Monotherapy in Pediatric Crohn's Disease: a Pragmatic Randomized Trial.
     Gastroenterology. 2023 Mar 31:S0016-5085(23)00538.
     

     >> Share

     
     
179. YANG Z, Qin J, Zhao L, Chen T, et al
     Host sorbitol and bacterial sorbitol utilization promote C. difficile infection in inflammatory bowel disease.
     Gastroenterology. 2023 Mar 8:S0016-5085(23)00238.
     

     >> Share

     
     
180. IACUCCI M, Parigi TL, Del Amor R, Meseguer P, et al
     Artificial Intelligence enabled histological prediction of remission or activity and clinical outcomes in ulcerative colitis.
     Gastroenterology. 2023 Mar 3:S0016-5085(23)00216.
     

     >> Share

     
     
181. NOVIELLO D, Facciotti F, Caprioli F
     Environmental Protective and Risk Factors in an At-Risk Population of Subsequent Crohn's Disease.
     Gastroenterology. 2023;164:500-501.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share